The Application of Goal Attainment Scaling in Cervical Dystonia – An Exploratory Observational Pilot Study

Background Due to its heterogeneous manifestation an individualized approach to reach therapeutic goals in cervical dystonia (CD) is advantageous. Objectives The aim of the current study was to adapt goal attainment scaling (GAS) to drive the management of CD. Methods 38 patients with CD, regularly...

Full description

Saved in:
Bibliographic Details
Published in:Movement disorders clinical practice (Hoboken, N.J.) N.J.), 2024-08, Vol.11 (8), p.1013-1017
Main Authors: Szabó, Máté, Gárdián, Gabriella, Szpisjak, László, Salamon, András, Gábor, Tamás, Klivényi, Péter, Zádori, Dénes
Format: Article
Language:English
Subjects:
Adult
Aged
botulinum neurotoxin
Botulinum Toxins - administration & dosage
Botulinum Toxins - therapeutic use
Botulinum Toxins, Type A - administration & dosage
Botulinum Toxins, Type A - therapeutic use
Brief Report
cervical dystonia
COL‐CAP
Female
goal attainment scaling
Goals
Humans
Male
Middle Aged
Neuromuscular Agents - administration & dosage
Neuromuscular Agents - therapeutic use
Pilot Projects
Torticollis - drug therapy
Treatment Outcome
ultrasound
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background Due to its heterogeneous manifestation an individualized approach to reach therapeutic goals in cervical dystonia (CD) is advantageous. Objectives The aim of the current study was to adapt goal attainment scaling (GAS) to drive the management of CD. Methods 38 patients with CD, regularly treated with botulinum neurotoxin (BoNT), were involved in the current exploratory observational pilot study. GAS, including domains of motor, pain, disability, and psychiatric features, was applied to set up individualized goals with the calculation of initial GAS T‐scores. Following at least 4 BoNT injection cycles, patients were reassessed whether they reached the pre‐set goals. Results The initial GAS T‐scores (median: 36.9, range: 22.8–40) significantly improved (P 
ISSN:2330-1619
2330-1619
DOI:10.1002/mdc3.14118